Status:
COMPLETED
Efficacy of Brief Acceptance and Commitment Therapy (ACT) for Perinatal Anxiety
Lead Sponsor:
University of Iowa
Conditions:
Post Partum Depression
Perinatal Depression
Eligibility:
FEMALE
18-45 years
Phase:
NA
Brief Summary
This protocol will test the hypothesis that Acceptance and Commitment Therapy (ACT) is effective in reducing anxiety and depressive symptoms during the perinatal and postpartum periods. Participants s...
Detailed Description
The study's major theme is "to examine the efficacy of a brief Acceptance and Commitment Therapy (ACT) intervention in treating perinatal anxiety symptoms, as compared to a supportive control conditio...
Eligibility Criteria
Inclusion
- Adult women (ages 18-45) who are between 18-26 weeks pregnant
- Fluency in English
- Ability to give informed consent and comply with study procedures (including phone and internet access)
- Elevated GAD-7 score (10+)
- Women must be receiving prenatal care
- Singleton pregnancy
Exclusion
- Prisoners
- Inability to give informed consent and comply with study procedures
- Past/current mania, past/current psychoses (assessed with Psychosis Screening Questionnaire)
- No therapy appointments in last 60 days (not currently in psychotherapy).
Key Trial Info
Start Date :
June 1 2020
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
June 30 2023
Estimated Enrollment :
30 Patients enrolled
Trial Details
Trial ID
NCT03837392
Start Date
June 1 2020
End Date
June 30 2023
Last Update
July 12 2023
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
University of Iowa
Iowa City, Iowa, United States, 52242